- Home
- MTEK vs TSBX Comparison
MTEK vs TSBX Comparison
Compare MTEK & TSBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEK
- TSBX
- Stock Information
- Founded
- MTEK 2008
- TSBX 2015
- Country
- MTEK Israel
- TSBX United States
- Employees
- MTEK N/A
- TSBX N/A
- Industry
- MTEK
- TSBX
- Sector
- MTEK
- TSBX
- Exchange
- MTEK Nasdaq
- TSBX Nasdaq
- Market Cap
- MTEK N/A
- TSBX 7.7M
- IPO Year
- MTEK 2022
- TSBX 2023
- Fundamental
- Price
- MTEK $3.02
- TSBX $0.36
- Analyst Decision
- MTEK
- TSBX Buy
- Analyst Count
- MTEK 0
- TSBX 3
- Target Price
- MTEK N/A
- TSBX $4.75
- AVG Volume (30 Days)
- MTEK 173.1K
- TSBX 479.7K
- Earning Date
- MTEK 08-27-2025
- TSBX 08-13-2025
- Dividend Yield
- MTEK N/A
- TSBX N/A
- EPS Growth
- MTEK N/A
- TSBX N/A
- EPS
- MTEK N/A
- TSBX N/A
- Revenue
- MTEK $6,078,953.00
- TSBX N/A
- Revenue This Year
- MTEK N/A
- TSBX N/A
- Revenue Next Year
- MTEK N/A
- TSBX N/A
- P/E Ratio
- MTEK N/A
- TSBX N/A
- Revenue Growth
- MTEK 50.80
- TSBX N/A
- 52 Week Low
- MTEK $1.45
- TSBX $0.29
- 52 Week High
- MTEK $6.47
- TSBX $2.69
- Technical
- Relative Strength Index (RSI)
- MTEK 56.61
- TSBX 52.27
- Support Level
- MTEK $2.65
- TSBX $0.33
- Resistance Level
- MTEK $3.44
- TSBX $0.37
- Average True Range (ATR)
- MTEK 0.44
- TSBX 0.03
- MACD
- MTEK 0.00
- TSBX -0.00
- Stochastic Oscillator
- MTEK 42.79
- TSBX 53.00
About TSBX Turnstone Biologics Corp.
Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.